TriSalus (TLSI) grants RSUs and stock options to director Kerry Hicks
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TriSalus Life Sciences director Kerry R. Hicks reported new equity awards and updated holdings. Hicks received 28,201 restricted stock units payable in common stock, which fully vest on May 14, 2026, subject to continued service. He was also granted 56,403 director stock options with a $2.52 exercise price, expiring on May 13, 2036, that vest on the same date. Following these grants, Hicks directly holds 542,790 shares of common stock and 145,625 director stock options. Indirect holdings include 1,370,028 shares through HW Investment Partners, LLC, 322,737 shares via The Kerry Raymond Hicks Dynasty Trust, and 81,845 shares held by Millennium Trust Company, LLC, with beneficial ownership in certain entities disclaimed except for his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
HICKS KERRY R
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) | 56,403 | $0.00 | -- |
| Grant/Award | Common Stock | 28,201 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Director Stock Option (right to buy) — 145,625 shares (Direct, null);
Common Stock — 542,790 shares (Direct, null);
Common Stock — 1,370,028 shares (Indirect, By HW Investment Partners, LLC)
Footnotes (1)
- Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The shares are held directly by The Kerry Raymond Hicks Dynasty Trust, for which the Reporting Person serves as trustee. The shares are held directly by Millennium Trust Company, LLC for which the Reporting Person acts as custodian. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
Key Figures
RSU grant: 28,201 units
Option grant: 56,403 options
Option exercise price: $2.52 per share
+5 more
8 metrics
RSU grant
28,201 units
Restricted stock units vesting May 14, 2026
Option grant
56,403 options
Director stock options granted May 14, 2026
Option exercise price
$2.52 per share
Director stock option strike price
Option expiration
May 13, 2036
Director stock option expiration date
Direct common shares
542,790 shares
Direct common stock holdings after transactions
Direct options held
145,625 options
Total director stock options after grant
HW Investment Partners holding
1,370,028 shares
Indirect common stock via HW Investment Partners, LLC
Dynasty Trust holding
322,737 shares
Indirect common stock via Kerry Raymond Hicks Dynasty Trust
Key Terms
restricted stock units, pecuniary interest, Dynasty Trust, Director Stock Option, +1 more
5 terms
restricted stock units financial
"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
Dynasty Trust financial
"The shares are held directly by The Kerry Raymond Hicks Dynasty Trust, for which the Reporting Person serves as trustee"
Director Stock Option financial
"Director Stock Option (right to buy) with an exercise price of 2.5200"
custodian financial
"The shares are held directly by Millennium Trust Company, LLC for which the Reporting Person acts as custodian"
A custodian is a financial institution that holds and safeguards an investor's assets—such as stocks, bonds, or cash—and records transactions on the investor's behalf. Think of it as a trusted caretaker or safe-deposit box for investments; it helps prevent loss or theft, handles paperwork and transfers, and provides transparency and regulatory checks, so investors can focus on decisions rather than the mechanics or security of asset storage.
FAQ
What equity awards did TriSalus (TLSI) director Kerry Hicks receive?
Kerry Hicks received 28,201 restricted stock units and 56,403 director stock options. The RSUs are payable in common stock, and the options carry a $2.52 exercise price, providing additional equity-based compensation linked to future service and company performance.
When do Kerry Hicks’ new TLSI RSUs and options vest?
Both the 28,201 restricted stock units and 56,403 director stock options fully vest on May 14, 2026. Vesting is conditioned on Hicks’ continued service with TriSalus Life Sciences through that one-year anniversary of the grant date.
What are the key terms of Kerry Hicks’ new TLSI stock options?
The director stock options cover 56,403 underlying common shares at a $2.52 exercise price and expire on May 13, 2036. They vest in full on May 14, 2026, assuming Hicks continues serving the company during that period.
What indirect TLSI holdings are associated with Kerry Hicks?
Indirectly, 1,370,028 shares are held by HW Investment Partners, LLC, 322,737 by The Kerry Raymond Hicks Dynasty Trust, and 81,845 by Millennium Trust Company, LLC. Hicks disclaims beneficial ownership of certain holdings except to the extent of his pecuniary interest.